172 related articles for article (PubMed ID: 16361139)
1. The clinical role of CT/PET in oncology: an update.
Francis IR; Brown RK; Avram AM
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S68-75. PubMed ID: 16361139
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Oncologic Imaging in Infants and Preschool Children With Substantially Reduced Radiation Exposure Using Combined Simultaneous ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging: A Direct Comparison to ¹⁸F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography.
Gatidis S; Schmidt H; Gücke B; Bezrukov I; Seitz G; Ebinger M; Reimold M; Pfannenberg CA; Nikolaou K; Schwenzer NF; Schäfer JF
Invest Radiol; 2016 Jan; 51(1):7-14. PubMed ID: 26309185
[TBL] [Abstract][Full Text] [Related]
3. PET and PET/CT in radiotherapy.
Könemann S; Weckesser M
Recent Results Cancer Res; 2008; 170():243-53. PubMed ID: 18019631
[No Abstract] [Full Text] [Related]
4. Role of (18)F-FDG PET-CT in head and neck squamous cell carcinoma.
Castaldi P; Leccisotti L; Bussu F; Miccichè F; Rufini V
Acta Otorhinolaryngol Ital; 2013 Feb; 33(1):1-8. PubMed ID: 23620633
[TBL] [Abstract][Full Text] [Related]
5. FDG-PET/CT imaging for staging and radiotherapy treatment planning of head and neck carcinoma.
Deantonio L; Beldì D; Gambaro G; Loi G; Brambilla M; Inglese E; Krengli M
Radiat Oncol; 2008 Sep; 3():29. PubMed ID: 18801181
[TBL] [Abstract][Full Text] [Related]
6. Positron emission tomography for radiation treatment planning.
Grosu AL; Piert M; Weber WA; Jeremic B; Picchio M; Schratzenstaller U; Zimmermann FB; Schwaiger M; Molls M
Strahlenther Onkol; 2005 Aug; 181(8):483-99. PubMed ID: 16044216
[TBL] [Abstract][Full Text] [Related]
7. The role of PET-CT in the management of patients with advanced cancer of the head and neck.
Corry J; Rischin D; Hicks RJ; Peters LJ
Curr Oncol Rep; 2008 Mar; 10(2):149-55. PubMed ID: 18377828
[TBL] [Abstract][Full Text] [Related]
8. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
9. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
Deniaud-Alexandre E; Touboul E; Lerouge D; Grahek D; Foulquier JN; Petegnief Y; Grès B; El Balaa H; Keraudy K; Kerrou K; Montravers F; Milleron B; Lebeau B; Talbot JN
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1432-41. PubMed ID: 16125870
[TBL] [Abstract][Full Text] [Related]
10. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.
Bradley J; Thorstad WL; Mutic S; Miller TR; Dehdashti F; Siegel BA; Bosch W; Bertrand RJ
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):78-86. PubMed ID: 15093902
[TBL] [Abstract][Full Text] [Related]
11. PET/CT: Radiation Therapy Planning in Head and Neck Cancer.
Eraj S; Sher DJ
PET Clin; 2022 Apr; 17(2):297-305. PubMed ID: 35256302
[TBL] [Abstract][Full Text] [Related]
12. Image-guided cancer therapy using PET/CT.
Yap JT; Carney JP; Hall NC; Townsend DW
Cancer J; 2004; 10(4):221-33. PubMed ID: 15383203
[TBL] [Abstract][Full Text] [Related]
13. Clinical applications of positron emission tomography-computed tomography in oncology.
Kumar R; Halanaik D; Malhotra A
Indian J Cancer; 2010; 47(2):100-19. PubMed ID: 20448371
[TBL] [Abstract][Full Text] [Related]
14. FDG PET and PET/CT imaging in lymphoma and melanoma.
Macapinlac HA
Cancer J; 2004; 10(4):262-70. PubMed ID: 15383207
[TBL] [Abstract][Full Text] [Related]
15. FDG PET Hybrid Imaging.
Becker J; Schwarzenböck SM; Krause BJ
Recent Results Cancer Res; 2020; 216():625-667. PubMed ID: 32594401
[TBL] [Abstract][Full Text] [Related]
16. F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer.
Koshy M; Paulino AC; Howell R; Schuster D; Halkar R; Davis LW
Head Neck; 2005 Jun; 27(6):494-502. PubMed ID: 15772951
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET/CT-guided intensity modulated head and neck radiotherapy: a pilot investigation.
Schwartz DL; Ford EC; Rajendran J; Yueh B; Coltrera MD; Virgin J; Anzai Y; Haynor D; Lewellen B; Mattes D; Kinahan P; Meyer J; Phillips M; Leblanc M; Krohn K; Eary J; Laramore GE
Head Neck; 2005 Jun; 27(6):478-87. PubMed ID: 15772953
[TBL] [Abstract][Full Text] [Related]
18. Utility of combined (18)F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors.
Roh JL; Kim JS; Lee JH; Cho KJ; Choi SH; Nam SY; Kim SY
Oral Oncol; 2009 Mar; 45(3):218-24. PubMed ID: 18804404
[TBL] [Abstract][Full Text] [Related]
19. Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer.
Guido A; Fuccio L; Rombi B; Castellucci P; Cecconi A; Bunkheila F; Fuccio C; Spezi E; Angelini AL; Barbieri E
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):759-63. PubMed ID: 18834671
[TBL] [Abstract][Full Text] [Related]
20. "Combined 18F-FDG-PET/CT imaging in radiotherapy target delineation for head-and-neck cancer": in regard to Guido et al. (Int J Radiat Oncol Biol Phys 2009;73:759-763).
Schinagl DA; Troost EG; Kaanders JH
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1629; author reply 1629. PubMed ID: 19515513
[No Abstract] [Full Text] [Related]
[Next] [New Search]